| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | Director | Stock Option (Right to Buy) | 53.5K | $171K | $13.42 | Oct 23, 2025 | Direct |
| Vigil Neuroscience, Inc. | Director | Stock Option Award (Right to Buy) | 0 | $138K | $7.62 | Aug 5, 2025 | Direct |
| Alaunos Therapeutics, Inc. | Director | Common Stock | 45K | $6.31K | $0.14 | Jun 22, 2022 | Direct |
| Vigil Neuroscience, Inc. | Director | Common Stock | 0 | $0 | $2.41 | Aug 5, 2025 | Direct |
| Alaunos Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 100K | Jun 6, 2023 | Direct | ||
| Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25.7K | Aug 8, 2024 | Direct | ||
| Entrada Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19K | Jun 11, 2025 | Direct |